Literature DB >> 6543841

Neonatal severe primary hyperparathyroidism and alkaptonuria in a boy born to related parents with familial hypocalciuric hypercalcemia.

B Steinmann, H E Gnehm, V H Rao, H P Kind, A Prader.   

Abstract

We describe a study of a boy with neonatal severe primary hyperparathyroidism (NSPHP) and alkaptonuria born to related parents of Turkish origin. The clinical and chemical courses (e.g. of mineral metabolism, of urinary excretion of amino acids and collagen metabolites) in response to various therapeutic approaches including total parathyroidectomy (PTX) are reported. Urinary excretion of calcium was unusually low before and immediately after PTX, and later during an inadvertent vitamin D intoxication. It corresponded to values typical for patients with familial hypocalciuric hypercalcemia (FHH), an autosomal dominant disorder. Both parents and one sibling had episodes of hypercalcemia with inappropriately high parathormone levels; in the father there was also relative hypocalciuria consistent with FHH. On the basis of the genetic and pathophysiologic data reported here, we speculate that homozygosity for the 'FHH-gene' is the cause of the life-threatening manifestation of NSPHP, whereas heterozygosity for the same gene leads to FHH, by comparison a mild disorder. The association of the two very rare recessively transmitted disorders, alkaptonuria and NSPHP, is unique; close linkage of the two genes, one coding for homogentisic acid oxidase, the other for the unknown gene product defective in NSPHP, can be suspected.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6543841

Source DB:  PubMed          Journal:  Helv Paediatr Acta        ISSN: 0018-022X


  12 in total

1.  Neonatal severe hyperparathyroidism: further clinical and molecular delineation.

Authors:  Fawziya A Al-Khalaf; Adel Ismail; Ashraf T Soliman; David E C Cole; Tawfeg Ben-Omran
Journal:  Eur J Pediatr       Date:  2010-10-23       Impact factor: 3.183

Review 2.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

3.  In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.

Authors:  M Bai; S H Pearce; O Kifor; S Trivedi; U G Stauffer; R V Thakker; E M Brown; B Steinmann
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

4.  Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.

Authors:  Stephen J Marx; Ninet Sinaii
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

5.  Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  M Bai; N Janicic; S Trivedi; S J Quinn; D E Cole; E M Brown; G N Hendy
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

6.  Neonatal hyperparathyroidism.

Authors:  B Steinmann; H E Gnehm; A Prader
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

Review 7.  Endocrine control and disturbances of calcium and phosphate metabolism in children.

Authors:  K Kruse
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

Review 8.  Familial hypocalciuric hypercalcaemia--familial benign hypercalcaemia: a review.

Authors:  J Auwerx; J Brunzell; R Bouillon; M Demedts
Journal:  Postgrad Med J       Date:  1987-10       Impact factor: 2.401

9.  Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia.

Authors:  Y H Chou; M R Pollak; M L Brandi; G Toss; H Arnqvist; A B Atkinson; S E Papapoulos; S Marx; E M Brown; J G Seidman
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

10.  Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity.

Authors:  H Heath; C E Jackson; B Otterud; M F Leppert
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.